Thyroid function and serum ferritin levels: The study of health in Pomerania

Thyroid

Volumn 16, Issue 7, 2006, Pages 681-686

  Völzke, Henry ^a   Wallaschofski, Henri ^a   Wolff, Birger ^a   Berger, Klaus ^b   John, Ulrich ^a   Dörr, Marcus ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DATA ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; GERMANY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; TURBIDIMETRY;

ADULT; AGED; FEMALE; FERRITINS; GERMANY; GOITER; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; RISK; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID GLAND; THYROTROPIN;

EID: 33747361266     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.681     Document Type: Article

References (35)

1. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study. Lancet 358:861-865.
2. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG 2004 Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591-2599.
3. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eberm B 2001 Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 142:838-842.
4. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252.
5. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G, Perticone F 2000 Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85:4701-4705.
6. Völzke H, Robinson DM, Schminke U, Lüdemann J, Rettig R, Felix SB, Kessler C, John U, Meng W 2004 Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 89:2145-2149.
7. Rosengreen A, Wilhelmsen L 1996 Fibrinogen, coronary heart disease and mortality from all causes in smokers and nonsmokers. The study of men born in 1933. J Intern Med 239:499-507.
8. Ridker PM, Buring JE, Cook NR, Rifai N 2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14719 initially healthy Amercan women. Circulation 107:391-397.
9. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM 2002 Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105:2595-2599.
10. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G 1998 Relationship between thyroid hormones and plasma D-dimer levels. Thrombosis and Haemostasis 79:99-103.
11. Erem C, Ersoz HO, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, Telatar M 2002 Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 25: 345-350.
12. Dörr M, Robinson DM, Wallawschofski H, Schwahn C, John U, Felix SB, Völzke H 2006 Low serum thyrotropin is associated with high plama fibrinogen. J Clin Endocrinol Metab 91:530-534.
13. Lin KH, Lee HY, Shih CH, Yen CC, Chen SL, Yang RC, Wang CS 2003 Plasma protein regulation by thyroid hormone. J Endocrinol 179:367-377.
14. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R 1992 High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86:803-811.
15. Wolff B, Völzke H, Lüdemann J, Robinson D, Vogelgesang D, Staudt A, Kessler C, Dahm JB, John U, Felix SB 2004 Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 35:453-457.
16. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F 1997 Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96:3300-3307.
17. Araujo JA, Romano EL, Brito BE, Parthe V, Romano M, Bracho M, Montano RF, Cardier J 1995 Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 15:1172-1180.
18. Lee TS, Shiao MS, Pan CC, Chau LY 1999 Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99:1222-1229.
19. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr., Vita JA 2001 Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 103:2799-2804.
20. Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, Weiss G 2002 Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol 40:2189-2194.
21. Takamatsu J, Majima M, Miki K, Kuma K, Mozai T 1985 Serum ferritin as a marker of thyroid hormone action on peripheral tissue. J Clin Endocrinol Metab 61:672-676.
22. Hashimoto T, Matsubara F 1989 Changes in the tumor marker concentration in female patients with hyper, eu-, and hypothyroidism. Endocrinol Jpn 36:873-879.
23. Macaron CI, Macaron ZG 1982 Increased serum ferritin levels in hyperthyroidism. Ann Intern Med 96:617-618.
24. Kubota K, Tamura J, Kurabayashi H, Shirakura T, Kobayashi I 1993 Evaluation of increased serum ferritin levels in patients with hyperthyroidism. Clin Invest 72:26-29.
25. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S, Kessler C 2001 Study of health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design. Soz Präventivmed 46:186-194.
26. Völzke H, Lüdemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U, Meng W 2003 The prevalence of undiagnosed thyroid disorders in a former iodine deficient area. Thyroid 13:803-810.
27. Völzke H, Alte D, Kohlmann T, Lüdemann J, Nauck M, John U, Meng W 2005 Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 15: 279-285
28. Gutekunst R, Becker W, Hehrmann H, Olbricht W, Pfannenstiel P 1988 Ultrasonic diagnosis of the thyroid gland. [Ultraschalldiagnostik der Schilddrüse.] Dtsch Med Wochenschr 113:1109-1112.
29. Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC 1981 Volumetric analysis of thyroid lobes by real-time ultrasound. [Volumetrie der Schilddrüsenlappen mittels Real-time-Sonographie.] Dtsch Med Wochenschr 106:409-414.
30. Moore M, Folsom AR, Barnes RW, Eckfeldt JH 1995 No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 141:719-723.
31. Ascherio A, Rimm EB, Giovannucci E, Willett WC, Stampfer MJ 2001 Blood donations and risk of coronary heart disease in men. Circulation 103:52-57.
32. Danesh J, Appleby P 1999 Coronary heart disease and iron status: Meta-analyses of prospective studies. Circulation 99:852-854.
33. Kirk EA, Heinecke JW, LeBoeuf RC 2001 Iron overload diminishes atherosclerosis in apoE-deficient mice. J Clin Invest 107:1545-1553.
34. Tuomainen TP, Diczfalusy U, Kaikkonen J, Nyyssonen K, Salonen JT 2003 Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. Free Radic Biol Med 35:922-928.
35. Zimmermann MB, Köhrle J 2002 The impact of iron and selenium deficiencies on iodine and thyroid metabolism: Biochemistry and relevance to public health. Thyroid 12:867-878.